Drug Database
L04AB04 adalimumab
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM AMGEVITA ▼
- POM Hulio 40 mg solution for injection in pre-filled syringe, Hulio 40 mg solution for injection in pre-filled pen
- POM Humira 20 mg / 0.2 ml Solution for Injection in Pre-Filled Syringe
- POM Humira 20 mg / 0.2 ml Solution for Injection in Pre-Filled Syringe (Northern Ireland)
- POM Humira 40 mg/0.4 ml Pre-filled Syringe and Pre-filled Pen (Great Britain)
- POM Humira 80 mg/0.8 ml Pre-filled Syringe and Pre-filled Pen
- POM Humira 80 mg/0.8 ml Pre-filled Syringe and Pre-filled Pen (Northern Ireland)
- POM Hyrimoz 20 mg solution for injection in pre-filled syringe (Great Britain) ▼
- POM Hyrimoz 20mg solution for injection in pre-filled syringe, Hyrimoz 40 mg solution for injection in pre-filled syringe and Hyrimoz 40 mg solution for injection in pre-filled pen ▼
- POM Hyrimoz 40 mg solution for injection in pre-filled syringe, Hyrimoz 40 mg solution for injection in pre-filled pen (Great Britain) ▼
- POM Idacio 40mg Solution - Prefilled syringe and Prefilled pen ▼
- POM Idacio 40mg Solution - Vial Paediatric use ▼
- POM Imraldi 40mg solution for injection in pre-filled pen
- POM Imraldi 40mg solution for injection in pre-filled syringe ▼
- POM Yuflyma 40 mg ▼
- POM Yuflyma 80 mg solution for injection in pre-filled pen
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).